Skip to content
Search

Latest Stories

Trailer of R Madhavan starrer Rocketry is interesting; Shah Rukh Khan also makes an appearance

Trailer of R Madhavan starrer Rocketry is interesting; Shah Rukh Khan also makes an appearance

By Murtuza Iqbal

R Madhavan has proved his mettle as an actor, and now, he is all set to make his debut as a director with the film Rocketry. It is a biopic on Nambi Narayanan, a former scientist and aerospace engineer of the Indian Space Research Organisation.


Madhavan plays the lead role in the film, and today, he has unveiled the trailer of the movie. He took to Instagram to share the trailer of the film. He posted, “Rocketry HINDI trailer @actormaddy @vijaymoolan #rocketrythefilm.”

Rocketry is a multi-lingual film and it will be released in Hindi, English, Tamil, Telugu and Kannada.

The trailer of the film is interesting, and R Madhavan is damn good as Nambi Narayanan. The movie also stars Simran Bagga, and though she has been given less scope in the trailer, she leaves a mark.

Well, the trailer is also a treat for Shah Rukh Khan fans because we get a glimpse of the actor in it. SRK has a cameo in the film, and reportedly, he plays the role of a journalist. While SRK will be seen in the English, Hindi, and Kannada versions, south star Suriya will be seen in the Tamil and Telugu versions.

While the release date of the film is not yet announced, the makers are planning to release it in Summer this year.

More For You

pharmacy

The UK spends just 9 per cent of healthcare budgets on medicines while patients face growing access gaps.

iStock

UK calls for new pharmaceutical investment to strengthen life sciences

Highlights

  • UK life sciences sector contributed £17.6bn GVA in 2021 and supports 126,000 high-skilled jobs.
  • Inward life sciences FDI fell by 58 per cent from £1,897m in 2021 to £795m in 2023.
  • Experts warn NHS underinvestment and NICE pricing rules are deterring innovation and patient access.

Investment gap

Britain is seeking to attract new pharmaceutical investment as part of its plan to strengthen the life sciences sector, Chancellor Rachel Reeves said during meetings in Washington this week. “We do need to make sure that we are an attractive place for pharmaceuticals, and that includes on pricing, but in return for that, we want to see more investment flow to Britain,” Reeves told reporters.

Recent ABPI report, ‘Creating the conditions for investment and growth’, The UK’s pharmaceutical industry is integral to both the country’s health and growth missions, contributing £17.6 billion in direct gross value added (GVA) annually and supporting 126,000 high-skilled jobs across the nation. It also invests more in research and development (R&D) than any other sector. Yet inward life sciences foreign direct investment (FDI) fell by 58per cent, from £1,897 million in 2021 to £795 million in 2023, while pharmaceutical R&D investment in the UK lagged behind global growth trends, costing an estimated £1.3 billion in lost investment in 2023 alone.

Keep ReadingShow less